Samantha Soldan

8PUBLICATIONS
48CO-AUTHORS
Haematological tumoursMolecular targetsNanotoxicology, health and safetyMedical virologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 06, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

Zhiwei Ang, Annette Castro, Luca Paruzzo

|Jan 20, 2025
First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.

A Dimitrios Colevas, Zahra Talebi, Elizabeth Winters

|Aug 10, 2023
EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls.

Maria Chiara G Monaco, Samantha S Soldan, Chenhe Su

|Aug 05, 2022
Epstein-Barr virus and multiple sclerosis.

Samantha S Soldan, Paul M Lieberman

Pageof 2